ImmunityBio, Inc., a biotechnology company, focuses on innovating, developing, and commercializing next-generation immunotherapies designed to activate the patient's immune system and deliver durable protection against cancer and infectious...
Q2 2026
Aug 4, 2026
Q1 2026
May 7, 2026
FY 2025
Feb 23, 2026
Q4 2025
Q3 2025
Nov 5, 2025
